Genetic risk assessment, monitoring of minimal residual disease in first remission, use of
targeted agents, and the newer transplant strategies all have the potential to …

Hematopoietic cell transplantation (HCT) has the potential to cure a number of malignant
and nonmalignant disorders. Mechanisms of cure include hematopoietic stem cell rescue …

Collaborative study groups have invested considerable effort in the last decade in defining
the role of allogeneic and autologous bone marrow transplantation as consolidation …

IL-6 family cytokines share structural similarities and utilize glycoprotein 130 (gp130) for
signal transduction. IL-6 itself has both pro-and anti-inflammatory effects. IL-6 trans-signaling …

Introduction: Optimal post-remission treatment for acute myeloid leukemia patients with
normal karyotype (AMLNK) in first complete remission (CR1) who lacks an HLA identical …

目的: 探讨自体外周血干细胞移植(APBSCT) 治疗急性白血病(AL) 的临床效果. 方法: APBSCT
治疗AL 患者11 例, 其中急性髓细胞白血病7 例, 急性淋巴细胞白血病4 例; AML …

Antecedentes: el esquema 7-3 se utiliza en la inducción a la remisión en pacientes con
leucemia mieloide aguda y es efectivo en 80% de los casos; sin embargo, la supervivencia …

Acute leukemia is the most common pediatric malignancy. Acute myelogenous leukemia
(AML) accounts for 20% of the cases of acute leukemia among children but causes a …

Favorable-risk acute myeloid leukemia (AML) is a subgroup of AML that has been shown to
have clinically unique behavior and improved response to therapy based on distinct …

The EORTC Leukemia Group comprises more than 45 qualified haematology centres in
Europe. The group promotes cooperation with new centres from Central and Eastern Europe …